DuPont Q1 2026 Earnings Show Organic Growth Drives Future Guidance

DuPont Q1 2026 earnings results (key reported metrics)

DuPont opened Q1 2026 with results that exceeded previously communicated guidance and delivered organic sales growth of 2%. ¹

Revenue / sales performance

• Net sales: $1.7 billion, up 4% year-over-year, comprised of 2% organic growth plus a 2% currency benefit. ²
• Organic growth drivers: Organic growth was led by health care and aerospace, partially offset by construction market softness and Middle East logistics disruptions that particularly impacted the water business. ²
• Segment organic growth:
  • Health Care & Water Technologies: 3% organic growth. ²
  • Diversified Industrials: ~flat organic growth. ²

Profitability and margins

• Operating EBITDA: $414 million, up 15% year-over-year, driven by organic sales growth, favorable mix, and productivity. ²
• Operating EBITDA margin (reported/pro forma framing):
  • Operating EBITDA margin: 24.6% in the quarter, up 230 bps year-over-year. ²
  • On a pro forma basis: operating EBITDA increased 10% and margins expanded 130 bps year-over-year. ²
• Corporate-level margin expansion commentary: The company also cited 130 bps of pro forma margin expansion tied to disciplined commercial and operational execution. ¹
• Operating EBITDA margin level (context): Operating EBITDA margin was 22.9%, expanding 110 bps versus the year-ago period. ³

EPS and cash flow

• Adjusted EPS (reported): $0.55, up 53% year-over-year. ²
• Adjusted EPS (pro forma): up 20% versus the prior year period. ²
• Transaction-adjusted free cash flow (FCF): $147 million, with 65% conversion. ²
• FCF outlook reiterated: Management stated free cash flow conversion remains on track, later noting FCF greater than 90% for 2026 remains expected. ⁴

Segment details

• Health Care & Water Technologies:
  • Net sales: $806 million, up 6% year-over-year with 3% organic growth and 3% currency benefit. ⁵
  • Organic growth: health care sales up high single digits organically; strength in medical packaging and biopharma, partially offset by Middle East logistics disruptions affecting industrial water and microelectronics. ⁵
• Diversified Industrials:
  • Net sales: $875 million, up 3% year-over-year with a 3% currency benefit; organic sales about flat. ⁵
  • Line of business signals: building technologies down low single digits (construction weakness); industrial technologies up low single digits (aerospace strength and automotive growth) partially offset by declines in printing/packaging. ⁵

---

How organic sales growth is expected to influence future guidance

DuPont linked the strong Q1 organic growth performance to raised full-year 2026 guidance, and also specified organic growth assumptions for upcoming quarters.

Q2 guidance: organic growth assumption explicitly built into sales forecast

For Q2 2026, management estimated:

• Net sales about $1.8 billion and adjusted EPS of $0.59, with assumed ~3% organic growth year-over-year. ³
• By segment organic growth expectations in Q2:
  • Healthcare & Water: mid-single-digit % organic growth, led by medical device, biopharma, and industrial water. ³
  • Diversified Industrial: low single-digit % organic growth, supported by aerospace and growth in printing/packaging, partially offset by continued construction market softness. ³

Interpretation: The guidance embeds organic growth as a primary operating lever for the top-line outlook. The company is not forecasting only currency or one-time factors; it explicitly assumes mid-single to low-single digit organic growth patterns by segment for Q2. ³

Full-year 2026 guidance: organic growth centered in the revised outlook

DuPont raised its full-year guidance and stated:

• Full-year net sales guidance now assumes about 4% organic growth, including ~1% from pricing actions to offset higher input costs due to the Middle East conflict. ⁶
• Currency is expected to be less than 1% tailwind for the full year (i.e., less supportive than earlier expectations). ⁶
• The guidance increase was attributed to its strong first quarter (and other items like interest income impacts), reflecting confidence that the organic growth trajectory can be sustained through the year. ⁶

How organic growth is expected to influence the rest of guidance:

• Operating profitability and EPS: Higher organic sales momentum in Q1 and the resulting execution contributed to the company raising full-year EPS range (to $2.35–$2.40) and improving the midpoint adjusted EPS by $0.10 versus prior guidance. ⁶
• Operating EBITDA midpoint: Full-year operating EBITDA at the midpoint is expected to be ~$1.745 billion, primarily reflecting stronger Q1 results partially offset by currency headwinds—again tying the guidance change to realized performance that is consistent with the organic growth outlook. ⁶
• Pricing component of organic growth: Management included ~1% of the assumed organic growth from pricing actions taken to offset higher input costs, indicating that organic growth guidance is expected to be supported by both volume/mix and commercial pricing recovery. ⁶

Management’s Q1-to-guidance bridge framing

• DuPont stated its Q1 performance delivered organic sales growth of 2% and pro forma margin expansion (130 bps), and then said it is raising full-year 2026 financial guidance as a result of that performance (plus interest income benefit and pricing impacts). ¹
• In segment execution, organic strength (notably in health care) and productivity were emphasized as contributors to margin and earnings in Q1, which supports management’s confidence in the organic growth-based guidance framework. ²⁵

---

Bottom line

• Q1 2026 results: DuPont reported net sales of $1.7B (+4% YoY) with 2% organic growth, operating EBITDA of $414M (+15% YoY), operating EBITDA margin of 24.6% (+230 bps), adjusted EPS of $0.55 (+53% YoY), and transaction-adjusted FCF of $147M with 65% conversion. ²
• Organic growth’s role in future guidance: Management’s forward guidance explicitly assumes continued organic momentum—~3% organic growth for Q2 and ~4% organic growth for full-year 2026 (with ~1% from pricing to offset Middle East-related higher input costs). ³⁶
• Effect on guidance: The company raised full-year net sales, operating EBITDA, and adjusted EPS in large part consistent with confidence that organic growth plus pricing actions and productivity can carry through the year, while currency tailwinds are expected to be smaller. ⁶¹